Search results
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid...
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSNKY) reported high-level results from an...
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment...
Benzinga via Yahoo Finance· 12 months agoThe FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used...
Birth control pill Opill may soon be available over the counter. Here’s what you need to know.
Yahoo Life Style via AOL· 1 year agoIf approved, the birth control pill Opill would be available just like any other over the counter...
Postmenopausal Bleeding: When Are Symptoms Concerning?
Verywell Health via Yahoo News· 6 months agoBleeding sometimes, but not always, suggests endometrial cancer Medically reviewed by Renita White,...
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) reported topline data from the DESTINY-Breast02 phase 3 trial of...
Understanding Needle Biopsy
Verywell Health via Yahoo News· 8 months agoA needle biopsy diagnoses cancer and other diseasesMedically reviewed by Steffini Stalos, DO A needle biopsy is a procedure to take a tissue sample....
Popular OTC medicines for colds and allergies don’t work, FDA panel says
CNN via Yahoo News· 9 months agoPhenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines, is...
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Benzinga via Yahoo Finance· 1 year agoMersana Therapeutics Inc (NASDAQ: MRSN) signed a deal for developing antibody-drug conjugates (ADCs)...
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer...
Benzinga via Yahoo Finance· 2 months agoOn Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s...
Roche Inks Second Drug Discovery Deal With Jnana Therapeutics
Benzinga via Yahoo Finance· 2 years agoRoche Holdings AG (OTC: RHHBY) has doubled down on a partnership with Jnana Therapeutics, paying $50...
